(Q34580894)

3 August 2017

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study (English)

1 reference

Sirkka Keinänen-Kiukaanniemi

3 August 2017

0 references

0 references

16

Matti Uusitupa

0 references

9

Sirkka Keinänen-Kiukaanniemi

0 references

Jaakko Tuomilehto

17

Jaakko Tuomilehto

0 references

Sirkka Aunola

Sirkka Aunola

4

0 references

Markku Peltonen

Markku Peltonen

3

0 references

Jaana Lindström

Jaana Lindström

Finnish Diabetes Prevention Study Group

1

0 references

18

Finnish Diabetes Prevention Study Group

1 reference

3 August 2017

2

Pirjo Ilanne-Parikka

1 reference

3 August 2017

5

Johan G Eriksson

1 reference

3 August 2017

15

Timo T Valle

1 reference

3 August 2017

7

Helena Hämäläinen

1 reference

3 August 2017

8

Pirjo Härkönen

1 reference

3 August 2017

11

Anne Louheranta

1 reference

3 August 2017

12

Marjo Mannelin

1 reference

3 August 2017

Katri Hemiö

6

1 reference

3 August 2017

Mauri Laakso

10

1 reference

3 August 2017

Merja Paturi

13

1 reference

3 August 2017

Jouko Sundvall

14

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

3 August 2017

1 reference

3 August 2017

368

1 reference

3 August 2017

9548

1 reference

3 August 2017

1673-1679

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

A Randomized Walking Trial in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969701-8

7 January 2021

10.1016/S0140-6736(06)69701-8

Identifiers

DOI

1 reference

3 August 2017

1 reference